
Kraig Biocraft Laboratories
(OTC) KBLB
Kraig Biocraft Laboratories Financials at a Glance
Market Cap
$132.45M
Revenue (TTM)
$0.00
Net Income (TTM)
-$3.97M
EPS (TTM)
-$0.00
P/E Ratio
-32.16
Dividend
$0.00
Beta (Volatility)
0.21 (Low)
Dividend
$0.00
Beta (Volatility)
0.21 (Low)
Price
$0.12
Volume
86,205
Open
$0.12
Price
$0.12
Volume
86,205
Open
$0.12
Previous Close
$0.12
Daily Range
$0.12 - $0.12
52-Week Range
$0.07 - $0.16
Estimated Earnings Date
May 13, 2026
Dividend
$0.00
Beta (Volatility)
0.21 (Low)
Price
$0.12
Volume
86,205
Open
$0.12
Previous Close
$0.12
Daily Range
$0.12 - $0.12
52-Week Range
$0.07 - $0.16
Estimated Earnings Date
May 13, 2026
KBLB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kraig Biocraft Laboratories
Industry
Chemicals
Sector
MaterialsEmployees
14
CEO
Kim K. Thompson
Website
www.kraiglabs.comHeadquarters
Ann Arbor, MI 48104, US
KBLB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
52%
Return on Assets
-1%
Earnings Yield
-3.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$132.45M
Shares Outstanding
1.11B
Volume
86.20K
Avg. Volume
1.37M
Financials (TTM)
Gross Profit
-$25.11K
Operating Income
-$3.37M
EBITDA
-$3.03M
Operating Cash Flow
-$1.79M
Capital Expenditure
-$5.40K
Free Cash Flow
-$1.79M
Cash & ST Invst.
$1.79M
Total Debt
$1.66M
Kraig Biocraft Laboratories Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$6.22K
-9.5%
Gross Margin
0.00%
N/A
Market Cap
$132.45M
N/A
Market Cap/Employee
$3.58M
N/A
Employees
37
N/A
Net Income
-$942.72K
-57.1%
EBITDA
-$819.28K
-80.5%
Quarterly Fundamentals
Net Cash
$1.18M
+190.9%
Accounts Receivable
$0.00
N/A
Inventory
$74.31K
+979.4%
Long Term Debt
$106.43K
+182.1%
Short Term Debt
$1.61M
-2.6%
Return on Assets
-1.07%
N/A
Return on Invested Capital
52.04%
N/A
Free Cash Flow
-$543.83K
-25.2%
Operating Cash Flow
-$529.72K
-21.9%